Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma

  1. Martinez-Lopez, J.
  2. Wong, S.W.
  3. Shah, N.
  4. Bahri, N.
  5. Zhou, K.
  6. Sheng, Y.
  7. Huang, C.-Y.
  8. Martin, T.
  9. Wolf, J.
Zeitschrift:
Blood Advances

ISSN: 2473-9537,  2473-9529

Datum der Publikation: 2020

Ausgabe: 4

Nummer: 14

Seiten: 3295-3301

Art: Artikel

DOI: 10.1182/BLOODADVANCES.2020002037 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus